See the DrugPatentWatch profile for Natesto
Natesto, a testosterone gel, is not currently available as a generic. The patent for Natesto has an expiration date of November 15, 2033 [1].
When does Natesto's patent expire?
Natesto's patent is set to expire on November 15, 2033 [1]. This means that, barring any extensions or legal challenges, generic versions of Natesto could potentially be approved and marketed by the U.S. Food and Drug Administration (FDA) after this date. DrugPatentWatch.com tracks patent expirations for various pharmaceuticals [1].
Can generic versions of Natesto be made?
Currently, generic versions of Natesto are not available. The drug is protected by patents, which grant the manufacturer exclusive rights for a certain period [1]. Once these patents expire, or if they are successfully challenged, the pathway for generic drug manufacturers to produce and sell their own versions of Natesto may open up.
What is the active ingredient in Natesto?
Natesto's active ingredient is testosterone [2]. It is used for testosterone replacement therapy in men who have low or no testosterone [2].